Department of Plastic Surgery, Peking University Third Hospital, Beijing, 100191, People's Republic of China.
Drug Des Devel Ther. 2021 Mar 1;15:905-917. doi: 10.2147/DDDT.S299641. eCollection 2021.
The potential of relapse of craniofacial disharmony after trans-sutural distraction osteogenesis is high due to the failure to produce a stable bone bridge in the suture gap. The aim of this study is to evaluate whether hydroxyapatite nanoparticles (nHAP) have the effect of promoting osteoblast differentiation of suture-derived stem cells (SuSCs) and bone formation in sagittal suture during expansion.
SuSCs were isolated from sagittal sutures and exposed to various concentrations of nHAP (0, 25, 50, and 100 μg mL) to determine the optimal concentration of nHAP in osteoblast differentiation via performing Western Blotting and RT-qPCR. Twenty 4-week-old male Sprague-Dawley rats were randomly assigned into 4 groups: SHAM (sham-surgery), distraction, ACS (absorbable collagen sponge) and ACS+nHAP groups. In the ACS and ACS+nHAP groups, saline solution and nHAP suspended in a saline solution were delivered by ACS placed across the sagittal suture, respectively. In the latter three groups, the suture was expanded for 14 days by 50 g of constant force via a W shape expansion device. Suture gap area, bone volume fraction (BV/TV) and bone mineral density (BMD) of sagittal sutures were assessed via micro-CT, while the mechanical properties of sagittal sutures were evaluated via nanoindentation test. The efficacy of nHAP on bone formation in sagittal suture was also evaluated via BMP-2 immunohistochemistry staining.
The expression of osteoblast related genes and proteins induced by 25μg mL nHAP were significantly higher than the other groups in vitro (p<0.05). Furthermore, treating with 25μg mL nHAP in vivo, the suture gap area was significantly reduced when compared with the distraction group. Correspondingly, the BV/TV, BMD, hardness and modulus of sagittal sutures were significantly increased in the ACS+nHAP group (p<0.05).
The 25μg mL dose of nHAP delivered by ACS can facilitate bone formation into the sagittal suture during expansion via inducing osteoblast differentiation of SuSCs.
由于缝间未能形成稳定的骨桥,经颅缝牵张成骨术后颅面协调性复发的可能性很高。本研究旨在评估纳米羟基磷灰石(nHAP)是否具有促进缝间衍生干细胞(SuSCs)成骨分化和扩张过程中矢状缝骨形成的作用。
从矢状缝中分离出 SuSCs,并将其暴露于不同浓度的 nHAP(0、25、50 和 100μg/ml)中,通过 Western Blotting 和 RT-qPCR 确定 nHAP 促进成骨分化的最佳浓度。将 20 只 4 周龄雄性 Sprague-Dawley 大鼠随机分为 4 组:SHAM(假手术)、牵张、ACS(可吸收胶原海绵)和 ACS+nHAP 组。在 ACS 和 ACS+nHAP 组中,分别通过 ACS 将生理盐水溶液和悬浮在生理盐水中的 nHAP 置于矢状缝中。在后三组中,通过 W 形扩张装置以 50g 的恒力将缝扩张 14 天。通过 micro-CT 评估矢状缝的缝间隙面积、骨体积分数(BV/TV)和骨密度(BMD),通过纳米压痕试验评估矢状缝的力学性能。通过 BMP-2 免疫组织化学染色评估 nHAP 对矢状缝骨形成的疗效。
体外实验中,25μg/ml nHAP 诱导的成骨相关基因和蛋白表达明显高于其他组(p<0.05)。此外,体内给予 25μg/ml nHAP 治疗后,与牵张组相比,缝间隙面积明显减小。相应地,ACS+nHAP 组的矢状缝 BV/TV、BMD、硬度和模量均显著增加(p<0.05)。
ACS 输送的 25μg/ml nHAP 剂量可通过诱导 SuSCs 成骨分化,促进扩张过程中矢状缝的骨形成。